| Cholesterol Metabolism and Lipid Transfer in Diabetes (NCT01010035) | University of Sao Paulo General Hospital | 2006-09-01 |
| Safety and Efficacy of Exenatide as Monotherapy (NCT00381342) | AstraZeneca | 2006-09-01 |
| A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus (NCT00437164) | GlaxoSmithKline | 2006-09-01 |
| Ready to Act - Health Education in People With Hyperglycaemia (NCT01945645) | University of Aarhus | 2006-09-01 |
| Exenatide Versus Glimepiride in Patients With Type 2 Diabetes (NCT00359762) | AstraZeneca | 2006-09-01 |
| A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes (NCT00382239) | AstraZeneca | 2006-09-01 |
| MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED) (NCT00372060) | Merck Sharp & Dohme LLC | 2006-08-21 |
| A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005) (NCT02004886) | Merck Sharp & Dohme LLC | 2006-08-11 |
| Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus (NCT00363519) | Ono Pharmaceutical Co., Ltd. | 2006-08-01 |
| Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus (NCT00363948) | Ono Pharmaceutical Co., Ltd. | 2006-08-01 |
| Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715 (NCT00365781) | Ionis Pharmaceuticals, Inc. | 2006-08-01 |
| Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes (NCT00376038) | GlaxoSmithKline | 2006-08-01 |
| Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus (NCT00363844) | Ono Pharmaceutical Co., Ltd. | 2006-08-01 |
| The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes (NCT00353834) | Joslin Diabetes Center | 2006-08-01 |
| Rehabilitation of Type 2 Diabetes Patients. (NCT00284609) | Bispebjerg Hospital | 2006-08-01 |
| Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation (NCT00974272) | Carl T. Hayden VA Medical Center | 2006-08-01 |
| LOADD (Lifestyle Over and Above Drugs in Diabetes) Study (NCT00124553) | Edgar National Centre for Diabetes Research | 2006-08-01 |
| Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment (NCT00361738) | Sanofi | 2006-07-01 |
| Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) (NCT00350779) | Merck Sharp & Dohme LLC | 2006-06-12 |
| Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus (NCT00335712) | Ono Pharma USA Inc | 2006-06-01 |
| Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) (NCT00541775) | Merck Sharp & Dohme LLC | 2006-06-01 |
| Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) (NCT00634673) | Hospital de Clinicas de Porto Alegre | 2006-06-01 |
| Lifestyle Intervention to Treat Diabetes in the Marshall Islands (NCT03862963) | University of Alabama at Birmingham | 2006-06-01 |
| Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea (NCT00327626) | Ionis Pharmaceuticals, Inc. | 2006-05-01 |
| Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus (NCT00361153) | Daiichi Sankyo | 2006-05-01 |
| Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT00387972) | GlaxoSmithKline | 2006-05-01 |
| Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. (NCT00328627) | Takeda | 2006-05-01 |
| Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study (NCT00486187) | Dr. Milan Gupta | 2006-04-01 |
| Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus (NCT00530881) | Phenomix | 2006-04-01 |
| MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040) (NCT00289848) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans (NCT00710008) | Landsteiner Institut | 2006-02-01 |
| Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes (NCT01145092) | Landsteiner Institut | 2006-02-01 |
| Metformin in Overweight Type 2 Diabetes Mellitus (NCT00922194) | Era's Lucknow Medical College | 2006-02-01 |
| The Incretin Effect in Patients With Chronic Pancreatitis (NCT00638573) | University Hospital, Gentofte, Copenhagen | 2006-01-01 |
| Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) (NCT00288236) | Sanofi | 2006-01-01 |
| Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone (NCT00282945) | Pfizer | 2006-01-01 |
| Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus (NCT00298844) | Odense University Hospital | 2006-01-01 |
| Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin (NCT00324363) | AstraZeneca | 2006-01-01 |
| Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy (NCT00253786) | Okayama University | 2005-11-11 |
| Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes (NCT00265746) | Medical University of Lodz | 2005-11-01 |
| Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics (NCT00330200) | Ionis Pharmaceuticals, Inc. | 2005-11-01 |
| The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females (NCT00254800) | AstraZeneca | 2005-11-01 |
| (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups (NCT00249314) | Hamilton Health Sciences Corporation | 2005-11-01 |
| A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes (NCT00240253) | AstraZeneca | 2005-10-01 |
| Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes (NCT00241423) | AstraZeneca | 2005-10-01 |
| A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients (NCT00349427) | GlaxoSmithKline | 2005-10-01 |
| In-patient Study in Patients With Type 2 Diabetes Mellitus (NCT00259896) | GlaxoSmithKline | 2005-10-01 |
| An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes (NCT00229658) | AstraZeneca | 2005-09-01 |
| Free Fatty Acids and Vascular Function in Subjects With Diabetes (NCT00153179) | Brigham and Women's Hospital | 2005-09-01 |
| Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin (NCT00231725) | Eli Lilly and Company | 2005-09-01 |
| Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) (NCT00131664) | Canadian Heart Research Centre | 2005-09-01 |
| An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) (NCT00130806) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes (NCT00106808) | Bristol-Myers Squibb | 2005-08-01 |
| DARE: Diabetes in cArdiac REhabilitation (NCT00354237) | Centre Hospitalier Universitaire Dijon | 2005-07-01 |
| A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) (NCT02012166) | Merck Sharp & Dohme LLC | 2005-07-01 |
| A Trial of Two Diets for Weight and Diabetes Management (NCT00729196) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-07-01 |
| A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) (NCT00127192) | Merck Sharp & Dohme LLC | 2005-07-01 |
| Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease (NCT00479986) | IKFE Institute for Clinical Research and Development | 2005-06-01 |
| Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women (NCT00440375) | Baskent University | 2005-06-01 |
| Korea National Diabetes Program (NCT01212198) | Kyunghee University Medical Center | 2005-05-01 |
| A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) (NCT00110435) | Organon and Co | 2005-05-01 |
| Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes (NCT00110864) | Wellstat Therapeutics | 2005-05-01 |
| Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT) (NCT00130481) | University of Florida | 2005-04-01 |
| Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) (NCT00110851) | Wellstat Therapeutics | 2005-04-01 |
| Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin (NCT00576784) | IKFE Institute for Clinical Research and Development | 2005-04-01 |
| MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036) (NCT00103857) | Merck Sharp & Dohme LLC | 2005-03-17 |
| Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (NCT00257257) | Sanofi | 2005-03-01 |
| Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention in Catalonia (NCT01519505) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2005-03-01 |
| Changes in Insulin Sensitivity After Weight Loss (NCT00627484) | Columbia University | 2005-03-01 |
| Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes (NCT00103935) | AstraZeneca | 2005-02-01 |
| Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole (NCT00205660) | Washington University School of Medicine | 2005-02-01 |
| Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes (NCT00373178) | Aristotle University Of Thessaloniki | 2005-01-01 |
| N-Acetylcysteine and Arginine Administration in Diabetic Patients (NCT00569465) | University of Turin, Italy | 2005-01-01 |
| AI(I)DA Acarbose and the Subclinical Inflammation (NCT00558883) | GWT-TUD GmbH | 2005-01-01 |
| A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes (NCT00517283) | AstraZeneca | 2005-01-01 |
| Effect of Mobile Communication With a Cellular Phone With a Glucometer on Glucose Control in Type 2 Diabetic Patients (NCT00412178) | The Catholic University of Korea | 2004-12-01 |
| Metabolic Effects of Alcohol (NCT00167115) | Bantle, John P., MD | 2004-12-01 |
| Acute Metabolic Effects of LAF 237 in Type 2 Diabetics (NCT00230464) | The University of Texas Health Science Center at San Antonio | 2004-11-01 |
| Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes (NCT00437008) | Ruhr University of Bochum | 2004-11-01 |
| Insulin Glulisine in Type 2 Diabetes Mellitus (NCT00310297) | Sanofi | 2004-11-01 |
| Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes (NCT00367055) | GlaxoSmithKline | 2004-10-01 |
| Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance (NCT00129233) | Nagoya University | 2004-10-01 |
| Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes (NCT00097500) | AstraZeneca | 2004-09-01 |
| Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 Diabetes (NCT00268541) | NHS Greater Glasgow and Clyde | 2004-09-01 |
| Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy (NCT00099619) | AstraZeneca | 2004-09-01 |
| Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients (NCT00147836) | Sun Yat-sen University | 2004-09-01 |
| Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027) (NCT00944450) | Merck Sharp & Dohme LLC | 2004-08-01 |
| A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes (NCT00318032) | University Hospitals, Leicester | 2004-08-01 |
| Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring (NCT00542698) | National Institute of Nursing Research (NINR) | 2004-07-01 |
| Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus (NCT00982358) | Charite University, Berlin, Germany | 2004-07-01 |
| Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes (NCT00377676) | VeroScience | 2004-07-01 |
| Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes (NCT00747409) | Munich Municipal Hospital | 2004-07-01 |
| Lifestyle Modification for Obesity-Related Type 2 Diabetes (NCT00415688) | Robert C. Atkins Foundation | 2004-07-01 |
| Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss (NCT00766298) | University of Pittsburgh | 2004-06-01 |
| MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043) (NCT00371007) | Merck Sharp & Dohme LLC | 2004-06-01 |
| Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes (NCT00123604) | St. Paul Heart Clinic | 2004-06-01 |
| Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat Diet (NCT00725257) | University of Campania Luigi Vanvitelli | 2004-06-01 |
| The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management (NCT00128336) | University of Otago | 2004-05-01 |
| An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial (NCT00754624) | Mannkind Corporation | 2004-05-01 |
| Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin (NCT00099320) | AstraZeneca | 2004-05-01 |